Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · February 26, 2013

Paclitaxel-Induced Neuropathy Risk Increased in Breast Cancer With CYP2C8*3 Variant

Annals of Oncology

 

Additional Info

Annals of Oncology
CYP2C8*3 Increases Risk of Neuropathy in Breast Cancer Patients Treated With Paclitaxel
Ann. Oncol 2013 Feb 14;[EPub Ahead of Print], DL Hertz, S Roy, AA Motsinger-Reif, et al

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading